Lexicon Pharmaceuticals Inc (LXRX) stock saw a modest uptick, ending the day at $0.79 which represents a slight increase of $0.10 or 14.49% from the prior close of $0.69. The stock opened at $0.7 and ...

Redwire Corp (RDW) stock saw a modest uptick, ending the day at $22.33 which represents a slight increase of $7.58 or 51.39% from the prior close of $14.75. The stock opened at $15.96 and touched a ...

HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...

HC Wainwright reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $42.00 ...

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of $118.00.

In a report released on January 17, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Summit Therapeutics (SMMT – Research ...

Fintel reports that on January 10, 2025, HC Wainwright & Co. initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) ...

On Tuesday, H.C. Wainwright analysts maintained a Neutral rating on CytomX Therapeutics (NASDAQ:CTMX) following the company's announcement of a corporate restructuring and the prioritization of ...

On Monday, H.C. Wainwright reaffirmed its Buy rating and $8.00 price target for ADC Therapeutics (NYSE:ADCT) stock, representing significant upside from the current price of $2.02. According to ...